Prostate cancer

Cancer research

Hypofractionated Radiotherapy for Prostate Cancer Shows Equivalent Efficacy to Conventional Radiation Therapy

Research has been conducted to compare the efficacy and toxicity profiles of isodose and dose-escalated hypofractionated radiotherapy (MHFRT) to conventional fractionated radiotherapy (CFRT) for prostate cancer. The study, led by researchers from the University of California Los Angeles (UCLA), analyzed individual patient data from seven phase 3 trials comparing MHFRT